Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000523696 | SCV000621079 | uncertain significance | not provided | 2017-09-25 | criteria provided, single submitter | clinical testing | The M3120T variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The M3120T variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). The M3120T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position where amino acids with similar properties to Methionine are tolerated across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Fulgent Genetics, |
RCV005027615 | SCV005657507 | uncertain significance | Van Maldergem syndrome 2; Hennekam lymphangiectasia-lymphedema syndrome 2 | 2024-04-28 | criteria provided, single submitter | clinical testing |